{"id":"https://openalex.org/W6992987984","doi":null,"title":"N-Methyl D-Aspartic Acid (NMDA) Receptors and Depression","display_name":"N-Methyl D-Aspartic Acid (NMDA) Receptors and Depression","alternate_titles":[],"publication_year":2009,"publication_date":"2009-03-01","ids":{"openalex":"https://openalex.org/W6992987984"},"language":"en","primary_location":{"id":"pmh:oai:dergipark.gov.tr:article/133470","doi":null,"is_oa":false,"landing_page_url":"http://dergipark.gov.tr/pgy/issue/11166/133470","pdf_url":null,"source":{"id":"https://openalex.org/S2764805218","display_name":"Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry","issn_l":"1309-0658","issn":["1309-0658","1309-0674"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","erih-plus","poland-20","tr-dizin"],"host_organization":"https://openalex.org/P4310318341","host_organization_name":"Psikiyatride G\u00fcncel Yakla\u015f\u0131mlar","host_organization_lineage":["https://openalex.org/P4310318341"],"host_organization_lineage_names":["Psikiyatride G\u00fcncel Yakla\u015f\u0131mlar"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"\\n Volume: 1, Issue: 1\\n 22-35\\n \\n","raw_type":"info:eu-repo/semantics/article"},"parent_works":[],"lineage":["https://openalex.org/W6992987984"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056656520","display_name":"Vahap Ozan Kotan","orcid":"https://orcid.org/0000-0003-0798-4850","observed_orcids":["https://orcid.org/0000-0003-0798-4850"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kotan, Vahap Ozan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102744918","display_name":"Salih Eker","orcid":"https://orcid.org/0000-0001-5972-2428","observed_orcids":["https://orcid.org/0000-0001-5972-2428"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eker, Salih Sayg\u0131n","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051185020","display_name":"Enver Yusuf Sivrioglu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sivrioglu, Enver Yusuf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5020910302","display_name":"Cengiz Akkaya","orcid":"https://orcid.org/0000-0001-9049-2413","observed_orcids":["https://orcid.org/0000-0001-9049-2413"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Akkaya, Cengiz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.016200000420212746,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.9950000047683716},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8600000143051147},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.6729999780654907},{"id":"https://openalex.org/keywords/hippocampal-atrophy","display_name":"hippocampal atrophy","score":0.8420000076293945},{"id":"https://openalex.org/keywords/synaptic-plasticity","display_name":"synaptic plasticity","score":0.9649999737739563},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.7480000257492065},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.9160000085830688},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.925000011920929},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.9210000038146973},{"id":"https://openalex.org/keywords/antidepressant-targets","display_name":"antidepressant targets","score":0.6000000238418579},{"id":"https://openalex.org/keywords/hippocampal-neurons","display_name":"hippocampal neurons","score":0.6620000004768372}],"concepts":[{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.6980000138282776},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6660000085830688},{"id":"https://openalex.org/C42251903","wikidata":"https://www.wikidata.org/wiki/Q18391002","display_name":"Monoaminergic","level":4,"score":0.6144999861717224},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5426999926567078},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.5397999882698059},{"id":"https://openalex.org/C200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","level":3,"score":0.489300012588501},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.4878999888896942},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4645000100135803},{"id":"https://openalex.org/C148762608","wikidata":"https://www.wikidata.org/wiki/Q3748185","display_name":"Hippocampal formation","level":2,"score":0.43720000982284546},{"id":"https://openalex.org/C73009533","wikidata":"https://www.wikidata.org/wiki/Q1517140","display_name":"Long-term depression","level":5,"score":0.427700012922287},{"id":"https://openalex.org/C2778875871","wikidata":"https://www.wikidata.org/wiki/Q4764954","display_name":"Animal models of depression","level":4,"score":0.4228000044822693},{"id":"https://openalex.org/C47611674","wikidata":"https://www.wikidata.org/wiki/Q849491","display_name":"Neuroplasticity","level":2,"score":0.40459999442100525},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.4041999876499176},{"id":"https://openalex.org/C98229152","wikidata":"https://www.wikidata.org/wiki/Q1551556","display_name":"Synaptic plasticity","level":3,"score":0.39559999108314514},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.38920000195503235},{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.3077000081539154},{"id":"https://openalex.org/C25274449","wikidata":"https://www.wikidata.org/wiki/Q1805481","display_name":"Long-term potentiation","level":3,"score":0.3052000105381012},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2865000069141388},{"id":"https://openalex.org/C2777134132","wikidata":"https://www.wikidata.org/wiki/Q188638","display_name":"Mood disorders","level":3,"score":0.2768999934196472},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.272599995136261},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2630999982357025},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2630000114440918},{"id":"https://openalex.org/C5687787","wikidata":"https://www.wikidata.org/wiki/Q5889850","display_name":"Homeostatic plasticity","level":5,"score":0.2590000033378601}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:dergipark.gov.tr:article/133470","doi":null,"is_oa":false,"landing_page_url":"http://dergipark.gov.tr/pgy/issue/11166/133470","pdf_url":null,"source":{"id":"https://openalex.org/S2764805218","display_name":"Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry","issn_l":"1309-0658","issn":["1309-0658","1309-0674"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","erih-plus","poland-20","tr-dizin"],"host_organization":"https://openalex.org/P4310318341","host_organization_name":"Psikiyatride G\u00fcncel Yakla\u015f\u0131mlar","host_organization_lineage":["https://openalex.org/P4310318341"],"host_organization_lineage_names":["Psikiyatride G\u00fcncel Yakla\u015f\u0131mlar"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"\\n Volume: 1, Issue: 1\\n 22-35\\n \\n","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2921913922","https://openalex.org/W2128411608","https://openalex.org/W2032302774","https://openalex.org/W2024054799","https://openalex.org/W2088577867","https://openalex.org/W2160011621","https://openalex.org/W2094297227","https://openalex.org/W2111247524","https://openalex.org/W2952344926"],"abstract_inverted_index":{"The":[0],"monoaminergic":[1],"hypothesis":[2],"of":[3,15,21,27,87,98,105,136,147,158,197,201,248,252],"depression":[4,51,166,198],"has":[5,19],"provided":[6],"the":[7,13,25,156,209,222,243,246,264],"basis":[8],"for":[9,24,77,239,245,266],"extensive":[10],"research":[11],"into":[12],"pathophysiology":[14],"mood":[16,230],"disorders":[17],"and":[18,52,65,90,108,162,177,199,225],"been":[20],"great":[22],"significance":[23],"development":[26],"effective":[28,191,206,269],"antidepressants.":[29],"Current":[30],"antidepressant":[31,54,270],"treatments":[32],"not":[33],"only":[34],"increase":[35,157],"serotonin":[36],"and/or":[37],"noradrenaline":[38],"bioavailability":[39],"but":[40],"also":[41,207],"originate":[42],"adaptive":[43],"changes":[44],"increasing":[45],"synaptic":[46,88],"plasticity.":[47],"Novel":[48],"approaches":[49],"to":[50,53,94,116,169,183,204,214,234,258],"therapy":[55],"are":[56,181,190,217],"now":[57],"focused":[58],"on":[59],"intracellular":[60],"targets":[61],"that":[62,71,122,155],"regulate":[63],"neuroplasticity":[64],"cell":[66,142],"survival.":[67],"Accumulating":[68],"evidence":[69,120],"indicates":[70,121],"there":[72],"is":[73],"an":[74,236],"anatomical":[75],"substrate":[76],"such":[78],"a":[79,260,267],"devastating":[80],"neuropsychiatric":[81],"disease":[82],"as":[83],"major":[84,165,249],"depression.":[85,250],"Loss":[86],"plasticity":[89],"hippocampal":[91,112,132],"atrophy":[92],"appear":[93,203],"be":[95,205,235,259],"prominent":[96],"features":[97],"this":[99],"highly":[100],"prevalent":[101],"disorder.":[102],"A":[103],"combination":[104],"genetic":[106],"susceptibility":[107],"environmental":[109],"factors":[110],"make":[111],"neurons":[113],"more":[114,268],"vulnerable":[115],"stress.":[117],"Abundant":[118],"experimental":[119],"stress":[123],"causes":[124],"neuronal":[125,141,186],"damage":[126],"in":[127,131,164,192,208,229,242,263],"brain":[128],"regions,":[129],"notably":[130],"subfields.":[133],"Stress-induced":[134],"activation":[135],"glutamatergic":[137],"transmission":[138],"may":[139,167],"induce":[140],"death":[143],"through":[144,171],"excessive":[145],"stimulation":[146],"N-methyl-D-aspartic":[148],"acid":[149],"(NMDA)":[150],"receptors.":[151],"Recent":[152],"studies":[153],"mention":[154],"nitric":[159],"oxide":[160],"synthesis":[161],"inflammation":[163],"contribute":[168],"neurotoxicity":[170],"NMDA":[172,178,188,253],"receptor.":[173],"Both":[174],"standard":[175],"antidepressants":[176],"receptor":[179,254],"antagonists":[180,189],"able":[182],"prevent":[184],"stress-induced":[185],"damage.":[187],"widely":[193],"used":[194],"animal":[195],"models":[196],"some":[200],"them":[202],"few":[210],"clinical":[211],"trials":[212],"performed":[213],"date.":[215],"We":[216],"still":[218],"far":[219],"from":[220],"understanding":[221],"complex":[223],"cellular":[224],"molecular":[226],"events":[227],"involved":[228],"disorders.":[231],"There":[232],"appears":[233,257],"emerging":[237],"role":[238],"glutamate":[240],"neurotransmission":[241],"search":[244,265],"pathogenesis":[247],"Attenuation":[251],"function":[255],"mechanism":[256],"promising":[261],"target":[262],"therapy.":[271]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6992987984","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-10-10T00:00:00"}
